Ocugen to Present at Retinal Vascular Disease Drug Development Summit

(marketscreener.com) MALVERN, Pa., Feb. 17, 2023 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that the Company’s Chief Scientific Officer, Arun Upadhyay, Ph.D., will participate in the Retinal Vascular Disease Drug Development Summit at the Hilton...https://www.marketscreener.com/quote/stock/OCUGEN-INC-19157135/news/Ocugen-to-Present-at-Retinal-Vascular-Disease-Drug-Development-Summit-43019137/?utm_medium=RSS&utm_content=20230217